or Try an Advanced Search...

    Technical Analysis for ELAN - Elanco Animal Health Incorporated

    Grade Last Price % Change Price Change
    D 13.26 1.69% 0.22
    ELAN closed up 1.69 percent on Friday, April 26, 2024, on 79 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 7
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical ELAN trend table...
    Date Alert Name Type % Chg
    Crossed Above 200 DMA Bullish 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish 1.69%
    Wide Bands Range Expansion 1.69%
    Gapped Down Weakness 1.69%
    Oversold Stochastic Weakness 1.69%
    Shooting Star Candlestick Bearish -0.38%
    1,2,3 Retracement Bearish Bearish Swing Setup -0.38%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.38%
    Wide Bands Range Expansion -0.38%
    Older End-of-Day Signals for ELAN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 18 hours ago
    10 DMA Resistance about 20 hours ago
    Up 2% about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    Up 1% about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ELAN Chart by TradingView
    Basic chart:

    Profile

    Elanco Animal Health Incorporated Description

    Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals in the United States and internationally. It offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and food animal products used in ruminant and swine production. The company caters to veterinarians and food producers of countries in North America, South America, Asia-Pacific, Europe, the Middle East, and Africa. Elanco Animal Health Incorporated was founded in 1954 and is based in Greenfield, Indiana. Elanco Animal Health Incorporated operates as a subsidiary of Eli Lilly and Company.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Life Sciences Pain Antibiotics Pet Animal Health Dermatology Enzymes Osteoarthritis Veterinary Medicine Food Producers Animal Product Animal Products Veterinary Physician

    Is ELAN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
    Apr 21 11 Best Low Price Pharma Stocks To Invest In
    Apr 17 Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
    Apr 1 Activist Ancora wins two board seats at Elanco Animal Health in settlement
    Apr 1 UPDATE 1-Elanco appoints two directors after settling with activist Ancora
    Apr 1 Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
    Apr 1 Activist investor Ancora secures two Elanco board seats, Bloomberg News reports
    Mar 12 Director William Doyle Acquires 15,000 Shares of Elanco Animal Health Inc (ELAN)
    Mar 5 The Cow is the How: Elanco Sees Methane Reduction as New Value Opportunity
    Mar 4 Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
    See more ELAN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.88
    52 Week Low 7.88
    Average Volume 4,099,988
    200-Day Moving Average 13.07
    50-Day Moving Average 15.37
    20-Day Moving Average 14.30
    10-Day Moving Average 13.34
    Average True Range 0.49
    RSI (14) 32.89
    ADX 37.97
    +DI 14.19
    -DI 34.26
    Chandelier Exit (Long, 3 ATRs) 14.93
    Chandelier Exit (Short, 3 ATRs) 14.17
    Upper Bollinger Bands 16.37
    Lower Bollinger Band 12.23
    Percent B (%b) 0.25
    BandWidth 28.96
    MACD Line -0.69
    MACD Signal Line -0.61
    MACD Histogram -0.0861
    Fundamentals Value
    Market Cap 6.53 Billion
    Num Shares 493 Million
    EPS -2.32
    Price-to-Earnings (P/E) Ratio -5.72
    Price-to-Sales 1.80
    Price-to-Book 1.28
    PEG Ratio 1.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.92
    Resistance 3 (R3) 13.88 13.62 13.81
    Resistance 2 (R2) 13.62 13.45 13.64 13.77
    Resistance 1 (R1) 13.44 13.35 13.53 13.48 13.74
    Pivot Point 13.18 13.18 13.23 13.20 13.18
    Support 1 (S1) 13.00 13.01 13.09 13.04 12.78
    Support 2 (S2) 12.74 12.91 12.76 12.75
    Support 3 (S3) 12.56 12.74 12.71
    Support 4 (S4) 12.60